Found 19 matching trials
A Study of the Safety and Effectiveness of LY3053102 in Participants With Type 2 Diabetes PHASE1 The purpose of this study is to investigate the safety and effectiveness of...
Show More Location
Orange County Research Center
Learn More & Join Trial
GLP-1 Receptor Agonist Therapy and Albuminuria in Patients With Type 2 Diabetes PHASE4 This is a prospective study to evaluate effect of Exenatide extended releas...
Show More Location
Diabetes Endocrinology Research Center of WNY
Learn More & Join Trial
Exenatide Once Weekly Over 2 Years as a Potential Disease Modifying Treatment for Parkinson's Disease PHASE3 This study is a clinical trial in patients with Parkinson's disease (PD), o...
Show More Location
University College London Hospital
Learn More & Join Trial
Pathophysiological Study of the Increase in Pancreatic Volume in Type 2 Diabetes Treatments. NA Incretinomimetics and inhibitors of dipeptidyl peptidase-4 (DPP-4) are new ...
Show More Location
Gastroenterology Department Erasme Hospital
Learn More & Join Trial
Exploratory Study to Investigate the Effect of Dapagliflozin and Exenatide Combined on Body Weight PHASE2 Obesity is a medical condition which increases the risk of other diseases, ...
Show More Location
Dept of Medical Sciences, Clinical Diabetes and Metabolism, Uppsala University and Section for Diabetes and Endocrinology at the Uppsala University Hospital
Learn More & Join Trial
Extended Release Exenatide Versus Placebo In Diabetic Patients With Type 4 Cardiorenal Syndrome PHASE3 Among adult individuals with type 2 diabetes mellitus and at risk for heart...
Show More Location
Baylor Scott and White Research Institute- Baylor Heart and Vascular Hospital
Learn More & Join Trial
Pilot Study of Bydureon to Treat Diabetes in HIV-infected Adults PHASE4 This pilot study will evaluate the effects of the anti-diabetic drug Bydure...
Show More Location
Vanderbilt University
Learn More & Join Trial
Assessment of Safety, Tolerability and Drug Levels of Exenatide Implant PHASE1 The purpose of this study is to evaluate the safety, tolerability and drug ...
Show More Learn More & Join Trial
Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension Period PHASE3 Primary Objective:
To demonstrate the superiority of the insulin glargine/...
Show More Location
Investigational Site Number 8400064
Learn More & Join Trial
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes PHASE2 The main purpose of this study is to compare the safety and effectiveness o...
Show More Location
John Muir Physician Network Clinical Research Center
Learn More & Join Trial